Financing ·
MDxHealth SA issued and sold 44,052,862 ordinary shares in a registered direct offering at $0.454 per share to…
MDXHMDxHealth SA
MDxHealth SA issued and sold 44,052,862 ordinary shares in a registered direct offering at $0.454 per share to institutional investors on August 13, 2026. The transaction generated approximately $20.0 million in net proceeds before expenses, which the company intends to use for working capital, product development, and commercialization expansion. Post-offering, total outstanding shares increased to 95,417,382. MDxHealth SA operates in the healthcare diagnostics industry, developing non-invasive tests for colorectal cancer screening.